Bariatric Metabolic Surgery Might be More of a Benefit than a Risk During a Pandemic Outbreak

<b><i>Introduction:</i></b> This report aimed to analyze the outcomes of patients with obesity who were on a bariatric program during the SARS-Cov-2 pandemic outbreak and compare those who received surgery with the ones who were not operated on. <b><i>Methods:</i></b> This was a retrospective study between 2020 and 2021. Patients were divided into two groups: those who underwent surgery (O) and those who were not operated (NO). The evolution of the risk factors identified for severe COVID infection and death was studied (ASMBS criteria). For this study, a follow-up period of 12 months was initiated. <b><i>Results:</i></b> In the O group, 83 patients were included and 99 were in the NO group. In the O group, patients with body mass index (BMI) > 35 Kg/m<sup>2</sup> before surgery resolved the condition in 73.5% (61) cases, and this was done in the first 30 days by 38 (45.7%). Type 2 diabetes mellitus remission was documented in 18 patients (85.7%) of the O group, and the mean time elapsed for remission was 102.2 days (<i>P</i> < .01). Hypertension remitted in 66.7% (20) of the patients in group O in 82.4 days (<i>P</i> < .01). The subgroup of patients with obesity and one high-risk associated condition (30.2%, 25) resolved both in 44% (11) cases and one in 48% (12) cases. In the group of patients with obesity and two high-risk associated conditions (15.6%, 13), 47% (6) patients resolved the three conditions, 38% (5) resolved two conditions, and 15% (2) resolved one condition. Among the NO group, no comorbidity resolutions were recorded (<i>P</i> < .01). Admission because of COVID infection was necessary for 7.1% of NO and 1.2% of O (<i>P</i> = .04). <b><i>Conclusion:</i></b> Bariatric metabolic surgery would not increase the risk of COVID infection or of suffering serious complications resulting from it. Patients undergoing bariatric metabolic surgery rapidly resolved high-risk comorbidities and had less need for hospitalization because of SARS-CoV-2 infection.

Authors

Institutions

Publication Details

Journal
Journal of Laparoendoscopic & Advanced Surgical Techniques
Published
2024-08-05
DOI
https://doi.org/10.1089/lap.2023.0535
Primary Topic
Bariatric Surgery and Outcomes
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Bariatric Metabolic Surgery Might be More of a Benefit than a Risk During a Pandemic Outbreak

Franco Signorini, Federico Moser, Martín Andrada, Nicolás Asis et al.
Journal of Laparoendoscopic & Advanced Surgical Techniques
Bariatric Surgery and Outcomes
article

Bariatric Metabolic Surgery Might be More of a Benefit than a Risk During a Pandemic Outbreak

Franco Signorini, Federico Moser, Martín Andrada, Nicolás Asis, Ignacio Rendeli, Sofía Ramirez, Lucio Obeide
article en

Abstract

<b><i>Introduction:</i></b> This report aimed to analyze the outcomes of patients with obesity who were on a bariatric program during the SARS-Cov-2 pandemic outbreak and compare those who received surgery with the ones who were not operated on. <b><i>Methods:</i></b> This was a retrospective study between 2020 and 2021. Patients were divided into two groups: those who underwent surgery (O) and those who were not operated (NO). The evolution of the risk factors identified for severe COVID infection and death was studied (ASMBS criteria). For this study, a follow-up period of 12 months was initiated. <b><i>Results:</i></b> In the O group, 83 patients were included and 99 were in the NO group. In the O group, patients with body mass index (BMI) > 35 Kg/m<sup>2</sup> before surgery resolved the condition in 73.5% (61) cases, and this was done in the first 30 days by 38 (45.7%). Type 2 diabetes mellitus remission was documented in 18 patients (85.7%) of the O group, and the mean time elapsed for remission was 102.2 days (<i>P</i> < .01). Hypertension remitted in 66.7% (20) of the patients in group O in 82.4 days (<i>P</i> < .01). The subgroup of patients with obesity and one high-risk associated condition (30.2%, 25) resolved both in 44% (11) cases and one in 48% (12) cases. In the group of patients with obesity and two high-risk associated conditions (15.6%, 13), 47% (6) patients resolved the three conditions, 38% (5) resolved two conditions, and 15% (2) resolved one condition. Among the NO group, no comorbidity resolutions were recorded (<i>P</i> < .01). Admission because of COVID infection was necessary for 7.1% of NO and 1.2% of O (<i>P</i> = .04). <b><i>Conclusion:</i></b> Bariatric metabolic surgery would not increase the risk of COVID infection or of suffering serious complications resulting from it. Patients undergoing bariatric metabolic surgery rapidly resolved high-risk comorbidities and had less need for hospitalization because of SARS-CoV-2 infection.

Journal of Laparoendoscopic & Advanced Surgical TechniquesVol. 34(11)
Hospital Privado (AR)
Good health and well-being
Openalex Percentile: Top 76%
Bariatric Surgery and Outcomes
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.